Bart Van Proeyen
Director in Consulting | Strategy, Analytics and M and A
Bart is responsible for building new capabilities at Deloitte EMEA towards global tier I & II Life Sciences clients with an integrated offering & assets on commercial analytics and precision insights, in close collaboration with Deloitte US. He has a professional background in commercial analytics across industries (life sciences, telco, utilities, retail, CPG), and is particulary strong at connecting the dots between business & IT.
Prior to joining Deloitte, he built his own venture KWARTS, where his team defined a “commercial analytics” offering in consulting, transformed it in a scalable SaaS platform in the area of “nextgen omnichannel/NBA” in Life Sciences. Under the hood, it contained a differentiating AI backbone, elaborated together with academics from Hasselt University (Belgium). After partnering with Deloitte, the KWARTS-platform was sold to Signum Life Science ApS, a Nordics-based solutions-and-data-provider, owned by the life sciences industry.